Brachial Plexus by Takahashi, Naoki & Narra, Vamsidhar
UNIT A14.1Brachial Plexus
Patients are usually referred to MR because of typical brachial plexus symptoms, which
include pain, numbness or weakness of the shoulder or arm. MR is the primary imaging
modality used to diagnose the cause of brachial plexopathy.
The Basic Protocol is the core component of this procedure. When a specific cause of
brachial plexopathy is suspected, modification of the Basic Protocol may be necessary.
For example, if the patient is suspected of having avulsion injury from trauma, use
Alternate Protocol 1. If neoplastic involvement of the brachial plexus is suspected or any
abnormalities are seen, use of intravenous contrast material is helpful (Alternate Protocol
2). When the patient has symptoms of thoracic outlet syndrome and vascular compression
is suspected, contrast enhanced MRA (magnetic resonance angiography) can be added
(Alternate Protocol 3).
The Basic Protocol takes ∼30 min, and Alternate Protocols take ∼45 min.
The parameters suggested here are based on experience with the Siemens 1.5 T Vision or
Symphony and 1.0 T Impact scanner and should be altered accordingly for different field
strengths and manufacturers. The flip angle of all turbo spin echo (fast spin echo)




IMAGING OF BRACHIAL PLEXUS
The brachial plexus has a relatively long and oblique course. The brachial plexus is formed
by C5 to T1 nerve roots, and runs along the subclavian and axillary arteries. Images are
obtained in transverse, coronal, and sagittal planes. A T1-weighted sequence is best for
delineating the anatomy with little motion artifact, and T2-weighted images with fat
suppression are helpful in characterizing the lesion. Flow-sensitive gradient echo se-
quences may be used when it is difficult to differentiate vascular structures from the lesion.
Table A14.1.1 lists the hardware necessary to perform the procedure, along with appro-
priate parameters. The available gradient strength will depend on the scanner, and the
echo times given in other tables may need to be varied accordingly (the smaller the
gradient strength, the longer the echo time for a particular scan).
NOTE: Be sure that technologists and nurses have immediate access to any emergency
equipment that may be relevant to a given study, or that may be needed for a particular
patient, such as crash carts or oxygen.
Set up patient and equipment
1. Interview (screen) the patient to ensure that he or she has no contraindications such
as cardiac pacemakers or defibrillator or other implants containing ferromagnetic
materials. Also be sure to find out if the patient has any health conditions that may
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Table A14.1.1 Equipment Parameters for Brachial Plexus
Coil type Torso phased-array coil or large flex coil
Gradient coil strength 25 mT/m (or whatever the system permits)
Cardiac gating No
Peripheral gating No
Use of contrast agent Yes, only used in Alternate Protocols 2 and 3
A14.1.1
Chest Wall
require the presence of special emergency equipment during the scanning procedure,
or necessitate any other precautions.
Generally standard screening forms are used for all patients scanned in a magnetic
resonance system.
The presence of any ferromagnetic metals may be a health hazard to the patient when he
or she is inside the magnet, and will also affect the imaging. If in doubt as to the exact
composition of the items, it is best to exclude patients with any metal implants; see Shellock
(1996) for discussion of what implants may be safely scanned using magnetic resonance.
Patients may be accompanied into the magnet room by a friend or family member, who can
sit in the room during the scan and comfort the patient as needed. This companion must
be screened as well to ensure the absence of loose metal objects on the body or clothing.
2. If the procedure is a research protocol, have the patient sign any necessary consent
form.
3. Have the patient remove all jewelry and change into a gown to eliminate any metal
that might be found in clothing.
4. Have the patient wash off any mascara and other makeup to avoid local tissue heating
and image artifacts.
5. Inform the patient about what will occur during the procedure, what he or she will
experience while in the magnet, and how to behave, including the following:
a. If earphones or headphones are used to protect the ears from the loud sounds
produced by the gradients, the patient will be asked to wear these, but will be able
to communicate with you at any time during the imaging.
b. The patient will be given a safety squeeze-bulb or similar equipment to request
assistance at any time (demonstrate how this works).
c. For good results the patient should not talk, and should avoid or minimize
swallowing or other movement, during each scan—i.e., as long as the banging
sounds continue. Between scans, talking and swallowing are allowed in most
cases, but should be avoided when comparative positional studies are being
performed; the patient will be informed when this is the case.
d. Nevertheless, the patient may call out at any time if he or she feels it necessary.
All the sequences are nonbreath-hold except for MRA sequence in Alternate Protocol 3 for
suspected thoracic outlet syndrome.
6. Help the patient mount onto the table. Either before or right after the patient lies down,
set up other monitoring equipment that is to be used.
7. Place the phased array coil high on the chest and neck. Place a towel as a block around
the neck to support the coil.
A large flex coil can also be used, but it is more difficult to position properly and has a
smaller FOV (field of view).
8. If needed, place a pillow or other support under the knees to make the patient more
comfortable.
9. Use the centering light to position the patient with the center at the patient’s sternum
and put him or her into the center of the magnet.
Sequence 1: Rapid three-plane positioning scout
10. For localization of subsequent acquisitions, run the system’s three-plane scout scan
according to Table A14.1.2.
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Sequence 2: 2-D Coronal T1-weighted turbo spin echo scan of bilateral brachial
plexus
Use the images from this coronal T1-weighted turbo spin echo sequence for an overview
of the bilateral brachial plexus. This is the only sequence obtained for the contralateral
side. The image of the contralateral brachial plexus would serve as a normal control to
check for symmetry.
11. Position a series of coronal slices off the scout images to ensure coverage of the
bilateral brachial plexus by including both acromioclavicular joints from side to side,
and mid C4 to below axilla from top to bottom. From anterior to posterior, start from
slightly anterior to the subclavian and axillary artery to slightly posterior to the neural
foramina of C4 to T1.
12. Run sequence 2 according to Table A14.1.3.
Sequence 3: 2-D Transverse T1-weighted spin echo sequence of symptomatic
brachial plexus
13. Position a series of transverse slices off the coronal T1-weighted images to ensure
coverage of the symptomatic brachial plexus by including mid vertebral body to the
acromioclavicular joint from side to side, and mid C4 to axilla from top to bottom.
14. Run sequence 3 according to Table A14.1.4.
Sequence 4: 2-D Sagittal T1-weighted spin echo sequence of symptomatic brachial
plexus
15. Position a series of sagittal slices off the coronal T1-weighted images from the anterior
scalene muscle to slightly lateral to the acromioclavicular joint.
16. Run sequence 4 according to Table A14.1.5.
Table A14.1.2 Primary Clinical Imaging Parameters for Pilot Scan (Sequence 1)
Patient position Supine
Scan type Gradient echo
Imaging plane (orientation) Three-plane: transverse, coronal,
and sagittal
Central slice or volume center Upper chest
Echo time (TE) 3.1 msec
Repeat time (TR) 6.5 msec
Flip angle (FA) 80°
Fields of view (FOVx, FOVy) 450 mm, 450 mm
Resolution (∆x, ∆y) 1.76 mm, 2.34 mm
Number of data points collected (Nx, Ny) 256, 192
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 5 mm
Number of slices 7
Slice gap Variable
Number of acquisitions (Nacq) 1
Swap read and phase encoding No
Slice locations Variable
Saturation pulses No
Scan time 8 sec
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Table A14.1.4 Primary Clinical Imaging Parameters for 2-D Transverse
T1-Weighted Spin Echo (Sequence 3)
Patient position Supine
Scan type Spin echo
Imaging plane (orientation) Transverse
Central slice or volume center Symptomatic brachial plexus
Echo time (TE) 14 msec
Repeat time (TR) 500 msec
Flip angle (FA) 90°
Fields of view (FOVx, FOVy) 200 mm, 200 mm
Resolution (∆x, ∆y) 0.78 mm, 1.04 mm
Number of data points collected (Nx, Ny) 256, 192a
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 5 mm
Number of slices 20
Slice gap 1 mm
Number of acquisitions (Nacq) 2
Swap read and phase encoding No
Saturation pulses No
Scan time 3 min, 53 sec
a20% phase oversampling.
Table A14.1.3 Primary Clinical Imaging Parameters for 2-D Coronal
T1-Weighted Turbo Spin Echo (Sequence 2)
Patient position Supine
Scan type Fast spin echo
Imaging plane (orientation) Coronal
Central slice or volume center Midline
Echo time (TE) 12 msec
Echo train length (ETL) 3
Repeat time (TR) 875 msec
Flip angle (FA) 160°a
Fields of view (FOVx, FOVy) 375 mm, 375 mm
Resolution (∆x, ∆y) 0.73 mm, 1.46 mm
Number of data points collected (Nx, Ny) 512, 256b
Display matrix (Dx, Dy) 512, 512
Slice thickness (∆z) 5 mm
Number of slices 15
Slice gap 1 mm
Number of acquisitions (Nacq) 3
Swap read and phase encoding No
Saturation pulses Inferior and superior
Scan time 4 min, 54 sec
aThe system displays the flip angle of the refocusing pulse. The flip angle of the first pulse of this
sequence is 90°.
b30% phase oversampling.
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Table A14.1.6 Primary Clinical Imaging Parameters for 2-D Sagittal
T2-Weighted Turbo Spin Echo with Fat Suppression (Sequence 5)
Patient position Supine
Scan type Fast spin echo
Imaging plane (orientation) Sagittal
Central slice or volume center Symptomatic brachial plexus
Echo time (TE) 99 msec
Echo train length (ETL) 11
Repeat time (TR) 3980 msec
Flip angle (FA) 160°a
Fields of view (FOVx, FOVy) 200 mm, 200 mm
Resolution (∆x, ∆y) 0.78 mm, 1.04 mm
Number of data points collected (Nx, Ny) 256, 192b
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 5 mm
Number of slices 20
Slice gap 1 mm
Number of acquisitions (Nacq) 3
Swap read and phase encoding No
Saturation pulses Fat suppression
Scan time 4 min, 16 sec
aThe system displays the flip angle of the refocusing pulse. The flip angle of the first pulse of this
sequence is 90°.
b20% phase oversampling.
Table A14.1.5 Primary Clinical Imaging Parameters for 2-D Sagittal
T1-Weighted Spin Echo (Sequence 4)
Patient position Supine
Scan type Spin echo
Imaging plane (orientation) Sagittal
Central slice or volume center Symptomatic brachial plexus
Echo time (TE) 14 msec
Repeat time (TR) 600 msec
Flip angle (FA) 90°
Fields of view (FOVx, FOVy) 200 mm, 200 mm
Resolution (∆x, ∆y) 0.78 mm, 1.04 mm
Number of data points collected (Nx, Ny) 256, 192a
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 5 mm
Number of slices 20
Slice gap 1 mm
Number of acquisitions (Nacq) 2
Swap read and phase encoding No
Saturation pulses Inferior over the heart
Scan time 4 min, 39 sec
a20% phase oversampling.
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Table A14.1.8 Primary Clinical Imaging Parameters for 2-D Sagittal Flow
Sensitive Gradient Echo (Sequence 7)
Patient position Supine
Scan type 2-D gradient echo
Imaging plane (orientation) Sagittal
Central slice or volume center Symptomatic brachial plexus
Echo time (TE) 9 msec
Repeat time (TR) 30 msec
Flip angle (FA) 30°
Fields of view (FOVx, FOVy) 200 mm, 200 mm
Resolution (∆x, ∆y) 0.78 mm, 1.04 mm
Number of data points collected (Nx, Ny) 256, 192a
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 5 mm
Number of slices 20
Slice gap 1 mm
Number of excitations (NEX) 20b
Number of acquisitions (Nacq) 1
Swap read and phase encoding No
Flow compensation Yes
Saturation pulses No
Scan time 2 min, 20 sec
a20% phase oversampling.
bThe number of concatenation is set to be 20. This means that only one slice will be excited during a
given repeat time.
Table A14.1.7 Primary Clinical Imaging Parameters for 2-D Sagittal Inversion
Recovery Turbo Spin Echo (Sequence 6)
Patient position Supine
Scan type Inversion recovery turbo spin echo
Imaging plane (orientation) Sagittal
Central slice or volume center Symptomatic brachial plexus
Echo time (TE) 30 msec
Echo train length (ETL) 7
Repeat time (TR) 5400 msec
Inversion time (TI) 155 msec
Flip angle (FA) 160°
Fields of view (FOVx, FOVy) 200 mm, 200 mm
Resolution (∆x, ∆y) 0.78 mm, 1.04 mm
Number of data points collected (Nx, Ny) 256, 192a
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 5 mm
Number of slices 20
Slice gap 1 mm
Number of acquisitions (Nacq) 1
Swap read and phase encoding No
Saturation pulses Inferior over the heart
Scan time 2 min, 59 sec
a20% phase oversampling.
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Sequence 5: 2-D Sagittal T2-weighted turbo spin echo sequence with fat suppression
of symptomatic brachial plexus
17. Positioning is the same as sequence 4. Run sequence 5 according to Table A14.1.6.
The T2-weighted sequence is useful in characterizing the lesions in the brachial plexus.
Sequence 6: 2-D Sagittal inversion recovery turbo spin echo sequence of
symptomatic brachial plexus (optional)
If the fat suppression is not adequately obtained with sequence 5, inversion recovery turbo
spin echo sequence is an alternative sequence.
18. Positioning is same as sequence 4. Run sequence 6 according to Table A14.1.7.
Sequence 7: 2-D Sagittal flow sensitive gradient echo sequence of symptomatic
brachial plexus (optional)
This sequence is an optional sequence, and can be performed to help differentiate vascular
structures from lesions.
19. Positioning is the same as sequence 4. Run sequence 7 according to Table A14.1.8.
ALTERNATE
PROTOCOL 1
IMAGING OF BRACHIAL PLEXUS FOR AVULSION INJURY
For patients with suspected avulsion injury of the nerve root, the Basic Protocol should
be modified and a coronal T2-weighted sequence of bilateral brachial plexus as well as a
transverse T2-weighted sequence of the symptomatic side are added. The sagittal T2-
weighted turbo spin-echo sequences in the Basic Protocol can be omitted.
Set up patient and equipment
1. Use the same equipment and the same patient setup as for the previous method (see
Basic Protocol, steps 1 to 9).
2. Run the same sequences 1 to 4 in Basic Protocol (see Basic Protocol, steps 10 to 16).
Table A14.1.9 Primary Clinical Imaging Parameters for 2-D Coronal
T2-Weighted Turbo Spin Echo (Sequence 8)
Patient position Supine
Scan type Fast spin echo
Imaging plane (orientation) Coronal
Central slice or volume center Midline
Echo time (TE) 99 msec
Echo train length (ETL) 13
Repeat time (TR) 4200 msec
Flip angle (FA) 160°a
Fields of view (FOVx, FOVy) 375 mm, 375 mm
Resolution (∆x, ∆y) 0.73 mm, 1.39 mm
Number of data points collected (Nx, Ny) 512, 270b
Display matrix (Dx, Dy) 512, 512
Slice thickness (∆z) 5 mm
Number of slices 15
Slice gap 1 mm
Number of acquisitions (Nacq) 2
Swap read and phase encoding No
Saturation pulses Inferior and superior
Scan time 3 min, 59 sec
aThe system displays the flip angle of the refocusing pulse. The flip angle of the first pulse of this
sequence is 90°.
b30% phase oversampling.
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Sequence 8: 2-D Coronal T2-weighted turbo spin echo sequence of bilateral brachial
plexus
3. Position a series of coronal slices off the scout images to ensure coverage of the
bilateral brachial plexus by including both acromioclavicular joints from side to side,
and mid C4 to below axilla from top to bottom. From anterior to posterior, start from
slightly anterior to the subclavian and axillary artery to slightly posterior to the neural
foramina of C4 to T1.
This is a high-resolution sequence and fat suppression is not used.
4. Run sequence 8 according to Table A14.1.9.
Sequence 9: 2-D Transverse T2-weighted turbo spin echo sequence of symptomatic
brachial plexus (with fat suppression)
5. Position a series of transverse slices off the coronal images to ensure coverage of the
symptomatic brachial plexus by including mid vertebral body to the acromioclavicu-
lar joint from side to side, and mid C4 to axilla from top to bottom.
6. Run sequence 9 according to Table A14.1.10.
ALTERNATE
PROTOCOL 2
IMAGING OF BRACHIAL PLEXUS FOR NEOPLASTIC INVOLVEMENT
If neoplastic involvement of the brachial plexus is suspected, the Basic Protocol should
be modified. Pre- and post-contrast T1-weighted spin-echo with fat suppression should
be performed. The post-contrast sequence increases the sensitivity to detect abnormalities
and help characterize the lesions. The image plane should be chosen which best depicts
the abnormality.
Table A14.1.10 Primary Clinical Imaging Parameters for 2-D Transverse
T2-Weighted Turbo Spin Echo with Fat Suppression (Sequence 9)
Patient position Supine
Scan type Turbo spin echo
Imaging plane (orientation) Transverse
Central slice or volume center Symptomatic brachial plexus
Echo time (TE) 99 msec
Echo train length (ETL) 11
Repeat time (TR) 4200 msec
Flip angle (FA) 160°
Fields of view (FOVx, FOVy) 200 mm, 200 mm
Resolution (∆x, ∆y) 0.78 mm, 1.04 mm
Number of data points collected (Nx, Ny) 256, 192a
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 5 mm
Number of slices 20
Slice gap 1 mm
Number of acquisitions (Nacq) 3
Swap read and phase encoding No
Saturation pulses Fat suppression
Scan time 4 min, 41 sec
a20% phase oversampling.




Normal saline (0.9% NaCl), sterile
Gadolinium-based MR contrast agent (e.g., Magnevist, Omniscan, or Prohance)
22-G intravenous catheter
Power injector (optional)
Set up patient and equipment
1. Use the same equipment and the same patient setup as for the previous method (see
Basic Protocol, steps 1 to 8).
2. Place a 22-G intravenous catheter in the antecubital fossa. Establish an intravenous
line from which the contrast agent can be injected, and attach this line securely to the
patient so that movement into or out of the magnet will not pull at the patient’s arm.
It is preferable to insert the line prior to imaging and to leave the patient in the magnet,
with no intervening motion between the scans run before contrast agent injection and those
run after injection.
3. Use the centering light to position the patient with the center at the patient’s sternum
and put him or her into the center of the magnet.
4. Run the same sequences 1 to 7 in Basic Protocol (see Basic Protocol, steps 10 to 19).
Sequence 10: 2-D T1-weighted spin echo sequence with fat suppression of
symptomatic brachial plexus before contrast agent injection
5. Choose the image plane which best depicts the lesion and run sequence 10 according
to Table A14.1.11. If no lesions are seen, choose transverse plane.
Table A14.1.11 Primary Clinical Imaging Parameters for 2-D T1-Weighted
Spin Echo with Fat Suppression (Sequences 10 and 11)
Patient position Supine
Scan type Spin echo
Imaging plane (orientation) The one that can best depict the
lesion
Central slice or volume center Symptomatic brachial plexus
Echo time (TE) 12 msec
Repeat time (TR) 410 mseca
Flip angle (FA) 90°
Fields of view (FOVx, FOVy) 200 mm, 200 mm
Resolution (∆x, ∆y) 0.78 mm, 1.04 mm
Number of data points collected (Nx, Ny) 256, 192b
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 5 mm
Number of slices 20
Slice gap 2 mm
Number of acquisitions (Nacq) 3
Swap read and phase encoding No
Saturation pulses Fat suppression
Scan time 6 min, 35 sec
aTR of 600 msec or less is preferred, if possible. This can be achieved in systems which can concatenate
the acquisition. If the system does not allow concatenation of the sequence, two sets of 10 slices can
be obtained separately.
b20% phase oversampling and a phase partial Fourier factor of 11/16.
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Sequence 11: 2-D T1-weighted spin echo sequence with fat suppression of
symptomatic brachial plexus after contrast agent injection
6. Leaving the patient in the magnet, administer 0.1 mmol/kg gadolinium contrast
intravenously. Flush the catheter with 5 ml normal saline. Run sequence 11 according
to Table A14.1.11.
The image plane and position should be same as sequence 10.
ALTERNATE
PROTOCOL 3
CONTRAST-ENHANCED MRA FOR THORACIC OUTLET SYNDROME
When thoracic outlet syndrome with vascular compromise is suspected, contrast-en-
hanced MRA can be added to the Basic Protocol. Two series of MRA images are obtained
with the patient’s arm in neutral position and above the shoulder. Double-dose gadolinium
contrast (e.g., 40 ml) is divided into half for each series. After the test bolus, one measure
for a pre-contrast mask and two measures for post-contrast MRA are obtained for each
series.
Materials
Normal saline (0.9% NaCl), sterile
Gadolinium-based MR contrast agent (e.g., Magnevist, Omniscan, or Prohance)
Power injector (for the MRA technique)
Set up patient and equipment
1. Use the same equipment and the same patient setup as for the previous method (see
Basic Protocol, steps 1 to 8).
2. Place a 22-G intravenous catheter in the antecubital fossa of the asymptomatic arm.
Establish an intravenous line from which the contrast agent can be injected, and attach
this line securely to the patient so that movement into or out of the magnet will not
pull at the patient’s arm.
Load the injection with a double dose (0.2 mmol/kg) of gadolinium contrast agent (this is
usually 40 ml or less).
It is preferable to insert the line prior to imaging and to leave the patient in the magnet,
with no intervening motion between the scans run before contrast agent injection and those
run after injection.
When the contrast material is injected from the symptomatic side, the vessels may appear
artificially narrowed and simulate disease on the MRA sequence because of the high-con-
centration of contrast material and the accompanying T2 shortening effect. To avoid this
artifact, the catheter should be placed in the asymptomatic arm.
3. Use the centering light to position the patient with the center at the patient’s sternum
and put him or her into the center of the magnet.
4. Use the same sequences 1 to 7 as in the Basic Protocol (see Basic Protocol, steps 10
to 19).
Sequence 12: Test bolus
5. Position a single transverse slice at the level of the aortic arch on screen.
6. Set up the injector for injection of 2 ml of gadolinium followed by 15 ml normal
saline at the rate of 2 ml/sec.
7. As you start the injector, start sequence 12 according to Table A14.1.12.
The sequence will acquire a single slice every second for 50 sec at the same location.
8. By scrolling the images, determine the time to the peak of contrast bolus arrival from
the start of contrast agent injection.
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Sequence 13: 3-D Pre-contrast MRA with the arm in neutral position (mask)
The pre-contrast sequence is obtained as a mask for subtraction and to ensure the coverage
and image quality.
9. Position the slab in coronal plane to cover the aortic arch and bilateral subclavian
arteries. Run sequence 13 according to Table A14.1.13 under breath-hold in inspira-
tion.
Table A14.1.12 Primary Clinical Imaging Parameters for Test Bolus (Sequence 12)
Patient position Supine
Scan type Gradient echo
Imaging plane (orientation) Transverse
Central slice or volume center Aortic arch
Echo time (TE) 2.4 msec
Repeat time (TR) 5.8 msec
Inversion time (TI) 300 msec
Flip angle (FA) 15°
Fields of view (FOVx, FOVy) 400 mm, 300 mm
Resolution (∆x, ∆y) 1.56 mm, 2.34 mm
Number of data points collected (Nx, Ny) 256, 128
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 10 mm
Number of slices 1
Slice gap Not applicable
Number of acquisitions (Nacq) 50
Swap read and phase encoding No
Saturation pulses No
Scan time 50 sec
Table A14.1.13 Primary Clinical Imaging Parameters for 3-D MRA, Mask
(Sequence 13)
Patient position Supine
Scan type 3-D gradient echo
Imaging plane (orientation) Coronal
Central slice or volume center Midline
Echo time (TE) 1.8 msec
Repeat time (TR) 4.6 msec
Flip angle (FA) 25°
Fields of view (FOVx, FOVy) 375 mm, 375 mm
Resolution (∆x, ∆y) 1.46 mm, 2.21 mm
Number of data points collected (Nx, Ny) 256, 170
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 3 mm (1.5 mm after interpolation)
Number of slices 34 (68 after interpolation)
Slice gap 0 mm
Number of acquisitions (Nacq) 1
Swap read and phase encoding No
ZIP 2 Yes
Saturation pulses No
Scan time 21 sec
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10. Check the images to ensure the coverage of the bilateral subclavian arteries and aortic
arch.
Minimal wrapping artifact does not interfere with the diagnostic ability of the study. The
degree of respiration artifact should be checked. If the patient cannot hold their breath long
enough, consideration should be given to shorten the scan time at the cost of spatial
resolution.
Sequence 14: 3-D Contrast-enhanced MRA with the arm in neutral position
11. Set up the injector for injection of half of the gadolinium (∼19 ml) followed by 15
ml normal saline at the rate of 2 ml/sec.
At this point, 21 ml of gadolinium is used (2 ml of gadolinium was used in the test bolus,
sequence 12). The other half of the gadolinium will be used in sequence 16, step 17.
12. Scan delay from the start of injection can be calculated based on time to peak of
contrast agent arrival determined by test bolus injection, injection duration, and scan
duration using following formula:
scan delay = time to peak + (injection duration)/2 − (scan duration)/2.
The scan time is typically 25 sec and injection duration is 9.5 sec (19 ml at 2 ml/sec). If the
time to peak at test injection is 15 sec, the scan delay would be 7 sec (= 15 + 9.5/2 − 25/2).
13. Position the slab exactly the same as in sequence 13.
The position should be copied from “history” so that subtraction can be performed later.
Two measures are performed in this sequence, and ∼8-sec interval should be allowed for
the patient to breathe between the first and second measures.
14. Start the injector, and after the scan delay as calculated in step 12, run sequence 14
according to Table A14.1.14 using a breath-hold in inspiration.
Sequence 15: 3-D Pre-contrast MRA with the arm above the shoulder (mask)
Even though the contrast agent has been injected during the previous scan, the word
“pre-contrast” is still used here to distinguish this sequence from sequence 16.
15. Change the patient’s arm position to above the shoulder.
16. Repeat steps 9 and 10 in this alternate protocol.
Sequence 16: 3-D Contrast-enhanced MRA with the arm above the shoulder
17. Set up the injector for the injection of the remaining gadolinium (∼19 ml), followed
by 15 ml normal saline at the rate of 2 ml/sec.
18. Repeat steps 11 to 14 in this alternate protocol.
Sequences 15 and 16 are exactly the same as sequences 13 and 14 except for the arm
position.
Data processing and viewing for sequences 13 to 16
19. Create subtraction data set from the pre- and post-contrast MRA sequences for each
arm position. Subtraction is essential for the second run (sequences 14 and 16) to
eliminate venous contamination from the first run. Display these data sets in maximal
intensity projection (MIP) and multi-planar reconstruction (MPR).





The brachial plexus provides motor and sen-
sory innervation to the upper extremity. A va-
riety of imaging techniques including com-
puted tomography (CT) and myelography have
been used in the past for assessment of the
brachial plexus. Currently, MR is considered
the modality of choice because of its multi-pla-
nar capability and good soft tissue contrast
(Posniak et al., 1993).
The brachial plexus is formed by the C5 to
T1 nerve roots, with inconstant contributions
from C4 and T2 nerve roots. The brachial
plexus courses anterolaterally to pass between
the anterior and middle scalene muscles, where
the three trunks are formed. Each trunk is di-
vided into two to four divisions, which run
along the superior aspect of the subclavian
artery in the supraclavicular fossa. Three cords
are formed from divisions, which run around
the axillary artery in the axilla.
Symptoms of brachial plexopathy include
numbness, pain or weakness involving multiple
root levels and multiple peripheral nerves. Bra-
chial plexopathy may be caused by various
pathologic entities including trauma, primary
neurogenic tumors or secondary neoplasms,
radiation injury, and neuritis.
Critical Parameters and
Troubleshooting
Fat suppression is used with the T2-weighted
turbo spin echo sequence. Fat suppression may
not be effective in some patients partly due to
field inhomogeneity near the surface of the
body. In those instances, use an inversion re-
covery sequence (sequence 6) to achieve fat
suppression.
Some authors advocate the use of ECG gat-
ing or respiratory compensation to eliminate
cardiac pulsatility or respiratory motion arti-
fact. The protocols described herein do not call
for the use of these techniques. If necessary,
ECG gating or respiratory compensation can
be used.
The only breath-hold sequence is the con-
trast-enhanced MRA sequence for suspected
thoracic outlet syndrome with vascular com-
pression. If the patient cannot hold his or her
breath for the period of the sequence (typically
22 to 25 sec), decrease the number of phase
encoding steps (Ny, or number of acquisitions)
to reduce the scan time.
Table A14.1.14 Primary Clinical Imaging Parameters for 3-D Contrast
Enhanced MRA (Sequence 14)
Patient position Supine
Scan type 3-D gradient echo
Imaging plane (orientation) Coronal
Central slice or volume center Midline
Echo time (TE) 1.8 msec
Repeat time (TR) 4.6 msec
Flip angle (FA) 25°
Fields of view (FOVx, FOVy) 375 mm, 375 mm
Resolution (∆x, ∆y) 1.46 mm, 2.21 mm
Number of data points collected (Nx, Ny) 256, 170
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 3 mm (1.5 mm after interpolation)
Number of slices 34 (68 after interpolation)
Slice gap 0 mm
Number of acquisitions (Nacq) 1
Number of repetitions 2 (with 8-sec time interval in
between)
Swap read and phase encoding No
ZIP 2 Yes
Saturation pulses No
Scan time 21 sec (50 sec with two
repetitions)




Figure A14.1.1 Normal brachial plexus. (A) Coronal and (B) sagittal T1-weighted images dem-
onstrate normal brachial plexus (arrows), which is a thin linear structure surrounded by fat and
running along the subclavian artery (arrow heads).





Figure A14.1.2 Brachial plexus involved by metastatic breast carcinoma. (A) Sagittal T1-weighted
image shows an isointense soft tissue mass (arrow) encasing the brachial plexus and subclavian
artery (arrow head). (B) On inversion recovery image, the mass is hyper-intense (arrow). The
subclavian artery (arrow head) is encased by the mass. (C) After administration of gadolinium
contrast, the mass shows enhancement (T1-weighted image with fat saturation) (arrow). Note the
encasement of the subclavian artery (arrow head) by the mass.




On T1-weighted images, the normal brachial
plexus appears as low signal fine linear struc-
ture that runs along the subclavian and axillary
artery (Fig. A14.1.1A, A14.1.1B). T1-weighted
images are best for delineation of anatomy
because of good soft tissue contrast between fat
and brachial plexus. T2-weighted images and
post-contrast T1-weighted images are good at
characterizing lesions.
Brachial plexopathy may result from pene-
trating or nonpenetrating trauma. Nonpenetrat-
ing injuries include avulsion injury, compres-
sion by adjacent fractures, or hematomas. On
MR, avulsion injury is recognized by a thick-
ened, folded appearance of the brachial plexus
and pseudomeningocele formation.
Primary neurogenic neoplasms are usually
intermediate in signal intensity on the T1-
weighted image and bright in signal intensity
A
B
Figure A14.1.3 Radiation fibrosis involving brachial plexus. (A) Coronal and (B) sagittal T1-
weighted images demonstrate soft tissue strands and loss of fat plane surrounding the right brachial
plexus (arrows). Compare with the normal brachial plexus on the left in the coronal image.
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on the T2-weighted image, and fusiform to
round in shape. After gadolinium administra-
tion, such neoplasms are typically enhanced. 
Involvement of the brachial plexus by sec-
ondary tumor is much more common than pri-
mary neurogenic tumors. The most common
secondary tumors to involve brachial plexus are
lung and breast carcinomas (Wittenberg and
Adkins, 2000). The brachial plexus may be
involved by tumors by direct extension as in
Pancoast tumor (lung carcinoma) or indirectly
from lymph node metastasis (Fig. A14.1.2).
Radiation brachial plexopathy can occur 18
months to 10 years after the radiation therapy.
It should be differentiated from recurrence of
the tumor. Evidence of edema (high signal on
the T2-weighted image) or fibrosis (low signal
on the T2-weighted image) depending on the
phase of radiation injury and lack of mass lesion
are the hallmark of MR findings (Fig. A14.1.3)
(Glazer et al., 1985; Bowen et al., 1996; Thya-
garajan et al., 1995).
Brachial plexus neuritis can be caused by
various different etiologies or can be idiopathic.
On MR, the brachial plexus is thickened and
high in signal intensity on T2-weighted images.
Thoracic outlet syndrome occurs because of
compression of brachial plexus or subclavian
artery in the scalene triangle or costoclavicular
space. Underlying skeletal abnormalities such
as a cervical rib or a fracture deformity of
clavicle or first rib can be responsible for the
compression. Other causes include fibromus-
cular band or spasm of scalene muscle. The
compression is often positional and subtle,
these abnormalities may be difficult to identify.
When vascular compression is present, a con-
trast enhanced MRA sequence may show
change in the caliber of the subclavian artery
in the position that produces the symptom.
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